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Abstract
Purpose: The	main	sign	of	osteoporosis	is	a	significant	decrease	of	bone	mass	that	is	caused	by	
imbalance	between	resorption	and	osteogenesis.	There	are	two	main	factors	that	contribute	to	the	
genesis	of	this	illness.	All	these	factors	bring	todecrease	of	thickness	of	bone	and	its	destruction	
doesn’t	depend	on	their	combination.	Therefore,	our	objective	was	to	study	the	changes	in	the	
alveolar	bones	of	elderly	people	in	secondary	edentulous.	Material and Methods:	For	deeper	
study	of	morphological	changes	in	segments	of	teeth	we	have	conducted	pathological	researches	
of	biopsy	material	of	dead	patients	at	the	Center	of	Pathological	Studies	of	the	Sumy	Medical	
University.	The	first	group	of	patients	included	n=7	who	died	of	various	somatic	abnormalities	
and	had	no	significant	atherosclerotic	lesions.	The	second	group	includes	segments	of	teeth	and	
jaws	of	patients	n=7	who	died	from	complications	of	atherosclerosis	In	our	studies,	we	used:	
Histological	study;	Fluorescence	microscopy;	Immunohistochemistry;	Microphotography	and	
image	analysis;	Mathematical	calculations.	Results: Based	on	 the	statistical	analysis	we	can	
see	a	downward	trend	in	the	number	of	osteocytes	in	trabeculae	of	the	periapical	third	part	of	
the	tooth	at	atherosclerosis	26.85±7.44;	P=0.05.	We	can	also	see	the	dependence	of	trabecular	
thinning	 of	 toothless	 area	 of	 the	 alveolar	 bone	 226.57±70.53;	 P=0.02	 from	 losing	 of	 teeth	
against	the	background	of	atherosclerosis	with	hypertension.	The	osteopontin	expression	and	
fluorescencetion	of	toothless	bone	area	also	tend	to	decrease	in	atherosclerosis	and	hypertension	
42.81±16.24;	P=0.048.	Conclusion: The	cause	of	tooth	loss	is	difficult	to	determine,	since	it	is	
not	clear	whether	it	is	due	to	osteoporosis	or	some	forms	of	periodontitis	in	patients.	The	bone	
resorption	 has	 actived	 by	 reactive	 oxygen	 species	 both	 during	 atherosclerosis.	Through	 our	
research	found	out	that	in	order	to	reduce	changes	in	the	toothless	bone	we	should	reduce	the	
pressure	on	chewing	toothless	alveolar	sprout	by	dental	implants.
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Introduction
The	main	problem	of	women	and	elderly	people	of	
both	sexes	nowadays	is	osteoporosis.	The	widespread	
consequence	of	osteoporosis	is	cervical	hip	fracture	
that	brings	down	quality	of	life	and	is	difficult	to	treat	
especially	 if	 old	 people	 are	 affected.	According	 to	
statistics	10-20%	of	people	with	cervical	hip	fracture	
die	within	half	a	year,	50%	never	regain	full	activity	
of	the	joint	and	they	cannot	walk	without	help,	and	
25%	demand	constant	care1.
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The	main	sign	of	osteoporosis	is	a	significant	decrease	
of	bone	mass	 that	 is	 caused	by	 imbalance	between	
resorption	 and	 osteogenesis.	 There	 are	 two	 main	
factors that contribute to the genesis of this illness. 
The	first	is	dysfunction	of	gonads	and	the	second	is	
aging.	After	 the	 age	 of	 40-50	 years	 people	 start	 to	
loose	from	0.3	tо	0.5%	of	bone	mass	per	year.	These	
numbers	grow	as	much	as	10	times	after	menopause	
(women)	or	castration	(men)	2.
In	the	process	of	bone	involution	a	significant	loss	of	
bone	stock	occurs	that	brings	to	senile	osteoporosis.	
The	bone	mass	decreases	with	 the	age.	This	 fact	 is	
proved	 by	 radiologic,	 X-ray,	 histologic	 and	 other	
methods 3.
Bones	of	old	people	are	more	fragile	especially	in	the	
places	where	there	is	more	of	spongy	substance.	With	
aging the ratio of soluble and non-soluble collagen 
significantly	 changes	 in	 favour	 of	 the	 last	 one.	
Elasticity	of	a	bone	depends	on	organic	 substances	
and	 its	 hardness	 depends	 on	 mineral	 substances.	
Combination	of	organic	and	non-organic	components	
gives sturdiness and elasticity to bones. Bones of 
small	 kids	 that	 contain	 more	 organic	 substances	
differ	 in	big	elasticity	and	seldom	break.	In	the	old	
age	when	non-organic	components	prevail	bones	on	
the contrary become less elastic and more fragile. As 
a	result	old	people	get	fractures	more	often	3.
Many	 definitions	 of	 osteoporosis	 that	 described	
different	results	like	fractions	and	fragility	of	bones	
were	offered	during	many	years.	More	precise	 and	
coherent	 definition	 of	 this	 disease	 that	 covers	 the	
whole	 spectrum	 of	 its	 symptoms	 and	 after-effects	
of	 bone	mass	 loss	 is	 the	 definition	 of	 osteoporosis	
as	a	disease	that	is	characterized	by	low	bone	mass	
and disturbance of microarchitecture of bone tissue 
that brings to an increase in fragility of bones and 
successive	increase	in	fracture	risks4.
Fractures	 are	 clinical	 symptoms	 of	 osteoporosis.	
They	 can	 be	 vertebral	 fractures,	 such	 as	 “Colles”	
fracture	of	the	distal	forearm,	and	hip	fractures.	But	
if	thickness	of	bone	tissues	decreases	fractures	may	
happen	in	other	places5.
Depending	 on	 the	 origin	 there	 are	 two	 types	 of	
osteoporosis.	 Primary	 osteoporosis	 appears	 in	
postmenopause	 or	 as	 a	 result	 of	 body’s	 aging	
(senile	 osteoporosis).	 Secondary	 osteoporosis	 is	
characterized by the loss of bone tissue as the result 
of	 thyrotoxicosis	 or	 hyperadrenocorticism6. Still 
it	 remains	 unexplored	 what	 kind	 of	 changes	 may	
occur	in	alveolar	bone	after	the	loss	of	teethIn	1948	
Albright and Reifenstein7	offered	to	divide	primary	
osteoporosis	into	two	types	because	on	the	one	hand	
it	 is	 connected	with	 loss	of	 estrogen	 in	menopause	
and	 on	 the	 other	 hand	 with	 body	 aging.	 This	
conception	was	representedby	Riggs	and	associates	
8	who	offered	to	define	loss	of	sponge	tissue	of	bone	
after	 menopause	 by	 term	 “osteoporosis	 of	 type	 I”	
and	 loss	 of	 sponge	 and	 cortical	 substance	 by	men	
and	women	in	the	result	of	aging	as	“osteoporosis	of	
type	II”.That	means	that	type	I	is	only	the	result	of	
absence	of	 endogenous	 estrogen	 in	woman’s	body;	
type	 II	 reflects	combined	 influence	of	effectiveness	
of	 bone	 resorption,	 secretion	 of	 parathyroid	
hormones,	sufficient	amount	of	calcium	and	vitamin	
D	and	digestion	of	mineral	components	by	a	human	
body. Recent studies have indicated that there is 
coexistence	of	nutritional	deficiencies	and	appreciable	
over nutrition in the form of central obesity and 
overweight.	 In	 developing	 countries	 one	quarter	 of	
the	population	is	obese,	which	may	be	risk	factors	for	
cardiovascular	disease	and	osteoporosis9,10.
There	are	certain	diseases	that	influence	the	process	
of bones mineralization, cause their dysfunction 
and	 increase	 the	 risk	 of	 osteoporosis.	They	 can	 be	
genetic	and	acquired.	One	of	them	is	leucosis11-15. We 
should understand that bones in the adult age reach 
the	 peak	 of	 bone	mass	 that	 starts	 to	 decrease	with	
age.	All	 these	 factors	bring	 todecrease	of	 thickness	
of	bone	and	 its	destruction	doesn’t	depend	on	 their	
combination.	Therefore,	our	objective	was	 to	study	
the	changes	in	the	alveolar	bones	of	elderly	people	in	
secondary edentulous.
Materials and methods
Pathomorphologicalresearches.Segments	 of	 jaws	
from	 live	 patients	 don’t	 meet	 the	 standards	 of	
orthopedic	treatment,	so	segments	of	teeth	and	jaws	
for	 histopathological	 researches	 were	 taken	 from	
dead	 patients.	 Patients	 under	 the	 study	 have	 died	
while	being	hospitalized	in	the	departments	of	Sumy	
Regional	Hospital.
For	 deeper	 study	 of	 morphological	 changes	 in	
segments	 of	 teeth	we	 have	 conducted	 pathological	
researches	of	biopsy	material	of	dead	patients	at	the	
Center of Pathological Studies of the Sumy Medical 
University.
All	patients	were	divided	into	two	groups.	The	first	
group	 (test	 group)	 of	 patients	 included	 n=7	 who	
died of various somatic abnormalities and had no 
significant	atherosclerotic	lesions.	The	second	group	
(study	 group)	 includes	 segments	 of	 teeth	 and	 jaws	
of	 patients	 n=7	 who	 died	 from	 complications	 of	
atherosclerosis (myocardial infarction, hemorrhagic 
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stroke,	mesenteric	thrombosis).
Criteria	 to	 include	 the	 patients	 into	 the	 researches	
were	as	follows:
•	 the	patient	had	defected	jaws;
•	 male	45-56	years;
•	 the	patient’s	voluntary	consent	to	treatment,	
signed	while	he	was	alive;
•	 examination	 and	 referral	 to	 autopsy	 signed	
by	the	head	of	the	medical	unit;
Taking	autopsy	material	 (toothless	alveolar	process	
and	 2	 alveolar	 bones	with	 a	 tooth)	 for	 histological	
examination carried	 out	 by	 Luer	 nippers.	 Luer	
nippers	 have	 the	 round	 shape	working	 part	 with	 a	
cavity	 inside,	 where	 cut	 fragments	 of	 investigated	
alveolar	process	were	located.
Histological study.	 Preparations	 stained	 with	
hematoxylin-eosin	 to	 study	 the	 morphological	
structure.	 Methods	 of	 dyeing	 with	 hematoxylin-
eosin	 of	 our	 modifications	 included	 the	 following	
steps:	 (a)	 fixing	material	 in	 the	 liquid	 Karnua;	 (b)	
decalcification	in	17%	EDTA	and	putting	material	in	
paraffin;	 (c)	washing	 de-paraffined	 sections	 in	 two	
changes	of	absolute	ethanol;	 (d)	processingsections	
with	hematoxylin	for	5	hours	at	37	°	C;	(e)	washing	
with	 running	 water	 for	 2-5	 minutes;	 (f)	 coloration	
sections	with	eosin	5	seconds	at	room	temperature;	
(g)	 dehydration	 in	 alcohol,	 xylene	 and	 washing	 in	
2	 changes	 karbol-xylene;	 (h)	 placing	 in	 Canadian	
balsam.
Fluorescence microscopy. Sections for coloring 
were	 applied	 to	 a	 glass	 slide	 and	 got	 dried	 in	 an	
incubator	at	37ᵒC	 for	12	hours.	De-paraffining	was	
performed	 according	 to	 the	 standard	 method	 by	
xylene	 and	 ethanol.	 Washed	 with	 0.9%	 sodium	
chloride	solution.	0.5	ml	0.01%	solution	of	acridine	
hydrochloride	in	0.5M	acetate	buffer	was	applied	on	
materials.	Incubated	for	15	minutes	at	37ᵒC.	Washed	
thoroughly	with	 tap	water	 and	 allowed	 to	 dry.	The	
structure	of	teeth	segments	was	studied	with	the	help	
of	fluorescent	microscope	МБИ	15	using	immersion	
lenses.
The	results	of	fluorescence	microscopy	were	assessed	
by	fluorescence	 intensity	 of	 bone	 by	 percentage	 of	
evaluation:
•	 lack	of	fluorescence	-	0%;
•	 low	positive	fluorescence	+	=	33,3%;
•	 medium	positive	fluorescence		++	=	66,6%;
•	 highly	positive	fluorescence	+++	=	100%.	
Immunohistochemistry.	 Paraffin	 sections	 have	 been	
produced	with	thick	3	-	5	microns,	de-paraffined	by	
the	 standard	 method	 followed	 by	 washing	 in	 PBS	
with	the	pH	7,4	rate.
De-masking	was	continued	for	30	minutes	in	a	citrate	
buffer.	 To	 block	 endogenous	 peroxidase	 sections	
were	incubated	for	10	minutes	in	1%	H
2
O
2
 solution 
and	 washed	 in	 phosphate	 buffer	 (PBS).	 Then	 they	
were	incubated	in	a	humid	chamber	at	temperature	of	
+37°C	for	30	minutes	with	serum	to	block	nonspecific	
antibody	binding.	Primary	antibodies	against	OPNT	
were	used.	Then	sections	were	incubated	in	a	humid	
chamber	 at	 temperature	 of	 +37°C	 for	 30	 minutes	
with	 secondary	 species-specific,	 conjugated	 with	
horseradish	 peroxidase	 antibody	 (1:200)	 produced	
by	 «Jackson	 Immuno	 Research»	 (USA).	 Sections	
were	washed	from	primary	and	secondary	antibodies	
three	times	in	PBS	with	addition	of	0,1%	Tween-20.	
Visualization	 of	 antigen-antibody	 complex	 was	
carried	 out	 using	 3,3’-diaminobenzidine	 activator	
peroxidase	 (DAB),	 where	 sections	 were	 incubated	
for	 2-3	minutes.	The	 nuclei	with	 negative	 reaction	
were	extra	painted	by	Mayer	hematoxylin.
The	 results	 of	 reaction	 of	 antigens	 with	 bone	
localization	(OPN)	were	assessed	by	the	percentage	
of evaluation:
•	 no	reaction	-	0%;
•	 low	positive	reaction	+	=	33,3%;
•	 medium	positive	reaction	++	=	66,6%;
•	 highly	positive	reaction	+++	=	100%.	
Microphotography and image analysis. 
Photographing	performed	with	the	microscope	«Carl	
Zeiss»	with	lenses	of	10	×,	40	×,	60	×	and	100	×.	Images	
have	 been	 shot	 with	 a	 digital	 camera	 «DCM310»	
with	a	resolution	of	5.0	M	pixels.	Image	specimens	
have	 been	 analyzed	 in	 a	 computer	 environment	
morphometric	program	«Digimizer»	and	determined	
the	average	values	of	morphometric	parameters:	the	
number	of	osteoblasts	and	osteoclasts,	the	thickness	
of the cortical layer of bone, trabecular number and 
area.
Mathematical	 calculations	 have	 been	 performed	
in	 the	 program	 STATISTICA	 8	 (Serial	 number	
31415926535898)	 using	 cluster	 analysis	 and	Ansar	
Bradley criteria.
Results
Jaw	 bone	 serves	 as	 a	 support	 organ	 of	 the	mouth,	
is	a	reserve	of	macro-	and	micronutrients,	performs	
exchange function, and forms a cavity for bone 
marrow.	Jaw	bone	is	sensitive	to	different	regulatory	
mechanisms,	as	well	as	exogenous	and	endogenous	
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influences.	 Adentia	 enhances	 endogenous	 and	
exogenous factors on the alveolar bone. According 
to	 the	 Wolf’s	 law	 of	 transformation	 any	 change	
of function entails anatomical and structural 
transformation. So adentia causes changes in the 
bone tissue.
Toothless	 jaw	 bone	 areas	 are	 all	 covered	 by	
periosteum.	 Periosteum	 of	 the	 alveolar	 process	
increases	the	elasticity,	firmness	and	resistance	of	the	
bone	to	mechanical	stress	during	the	act	of	chewing.	
We	observed	two	layers	of	outer	periosteum	(fibrous)	
(Figure 1) and internal (Figure 2) osteogenic of the 
dead	patients	in	the	control	group.
The	cell	structure	of	the	fibrous	layer	is	represented	
by	a	small	number	of	immune	cells	and	fibroblasts,	
which	are	located	along	the	collagen	fibers.
The	inner	osteogenic	layer	of	the	periosteum	is	formed	
by	osteocytes	and	osteoblasts,	which	gradually	form	
a small number of osten (Figure 2-B).
Toothless	jaw	portion	of	patients	with	hypertension	
and	 atherosclerosis	 has	 significant	 morphological	
changes	 in	 the	 periosteum	 (Figure 3).	 There	 is	 a	
significant	 swelling	 between	 collagen	 fibers	 of	 the	
fibrous	layer	of	the	periosteum	(Figure 3-C).	There	
is	a	significant	lacunar	resorption	in	the	osteogenous	
layer (Figure 3-A),	which	reaches	osten.	The	number	
of	osten	rows	decreases	to	6±3.
Sponge	 filling	 toothless	 alveolar	 ridge	 forms	 a	
lamellar	 bone,	 which	 in	 its	 turn	 forms	 trabeculae	
(Figure 4).	Trabeculae	are	composed	of	several	layers	
of	bony	plates	8±2.	Trabecular	thickness	varies	and	
ranges	from	0.3-0.8	mm.	Trabeculae	are	covered	by	
endoost (Figure 4-V).	Trabeculae	space	is	formed	by	
loose	 connective	 tissue	with	 blood	 vessels	 (Figure 
4-C).
A	 common	 contraindication	 for	 dental	 implants	 is	
cardiovascular	disease,	which	in	most	cases	is	caused	
by	hypertension,	atherosclerosis	and	arteriosclerosis.	
Atherosclerosis	 and	 arteriosclerosis	 lead	 to	 poor	
blood	supply	to	the	bone	and	as	a	result	to	ischemia.	
On	the	one	hand	changes	in	the	spongy	bone	of	the	
toothless	 alveolar	 process	 are	 caused	 by	 atrophy	
under	 the	 influence	 of	 masticatory	 load.	 On	 the	
other hand they are cumulated by atherosclerosis 
and arteriosclerosis violations in average diameter 
arteries	 and	 potentiate	 changes	 in	 arterioles	 on	 the	
hypertension	background.
Patients	 of	 experimental	 group	 had	 macroscopic	
changes	in	all	parts	of	the	aorta	(Figure 5).
Figure 6	demonstrates	changes	of	arterioles	spongy	
alveolar	process	of	the	A3	patient	on	a	background	of	
significant	 atherosclerotic	 lesions	 of	 the	 abdominal	
aorta	and	hypertension	of	III	stage	rate	3.
Combination	 of	 hyalinosis,	 hypertrophy	 and	
necrosis	of	the	vascular	wall	was	observed	in	all	the	
investigated	samples	of	the	patients	with	hypertension	
and atherosclerotic lesions in the aorta.
Sponge	filling	toothless	alveolar	process	has	changed	
in	 most	 patients	 of	 the	 experimental	 group.	 We	
observed	 the	 absence	 of	 endoost	 in	 a	 large	 space	
of trabeculae (Figure 7-B).	 Lacunar	 resorption	 is	
progressed	 in	 trabeculae	 (Figure 7-B).	Bone	plates	
were	partially	resorptedand	had	scalloped	look.	Out	
of	trabekulae	space	was	characterized	by	the	growth	
of connective tissue (Figure 7-C).	Osteoclasts,	which	
formed	gaps,	were	seen	on	the	surface	of	trabeculae.
These	changes	indicated	a	strengthening	of	atrophy	
of	alveolar	process	against	the	background	of	somatic	
disorders.
Fibers	 of	 collagen-like	 proteins,	 collagen	 and	
elastin,	which	surrounded	connective	tissue	cells,	as	
well	 as	 osteoblasts	 and	 osteocytes	 have	 the	 ability	
to	 fluorescent	 under	 the	 influence	 of	 ultraviolet	
radiation. We have examined the distribution of 
collagen-like	bone	proteins	using	auto-fluorescent.
So	the	spatial	orientation	of	the	collagen-like	proteins	
in	a	bone	(proteoglycans,	which	are	related	to	the	1st	
type	of	collagen	and	glycoprotein)	could	be	localized.
Based on our observations it could be argued that 
unstructured	 placing	 of	 collagen-like	 proteins	 in	
trabeculae	was	observed	in	patients	with	hypertension	
and aortic atherosclerotic (Figure 8-A).	Trabeculae	of	
patients	without	atherosclerosis	had	a	linear	distribution	
of	 collagen-like	 proteins.	 Fluorescence	 of	 the	
trabeculae	was	little	more	intense,	and	it	corresponded	
to	 the	 number	 of	 amino	 which	 were	 composed	 of	 a	
ring	chemical	structure	(tryptophan,	proline,	 tyrosine,	
histidine,	phenylalanine)	(Figure 8-C).
During	the	study	of	the	periapical	part	of	the	alveolar	
bone,	 bone	 tissue	 was	 composed	 of	 external	 and	
internal	 cortical	 plates.	 The	 direction	 of	 trabecular	
bone	responded	the	vector	of	mechanical	stress	on	the	
teeth.	The	control	group	of	patients	(Figure 9-I) had 
a	uniform	periodontal	 slit	with	a	properly	arranged	
collagen	fibers	without	pathological	changes.
Patients	 with	 atherosclerosis	 and	 hypertension	
(Figure 9-II)	 were	 characterized	 by	 the	 resorptive	
changes	 in	 external	 and	 internal	 cortical	 plates	 to	
form	 resorption	 lacunae	 (Figure 9-D).	 Resorption	
lacunae	were	filled	with	fibrous	tissue	with	randomly	
arranged	collagen	and	elastic	fibers.	Changes	in	the	
cement	 of	 the	 tooth	 root	were	 not	 observed	 in	 the	
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studied	 groups.	 Changes	 in	 the	 periapical	 part	 of	
the	 alveolar	 bone	 in	 patients	 with	 atherosclerosis	
and	 hypertension	 were	 more	 in	 the	 toothless	 area	
of	 alveolar	 process.	We	 also	 noted	 the	 presence	 of	
hyalinosis	arterioles	in	periapical	arteries,	indicating	
a	complicated	course	of	hypertension,	ischemia	and	
resultant	periodontal	tissues.
Epithelium	 of	 toothless	 jaws	 area	 (control	 group),	
after	the	tooth	had	been	extracted,	was	characterized	
by	changes	due	to	the	influence	of	masticatory	load.	
Outgrowths	 in	 lamina	 propria	 were	 small	 in	 size.	
Stratification	 of	 epithelium	 was	 preserved.	 The	
surface	was	capable	to	keratinization	(Figure 10-I). 
Epithelium	looked	like	“chewing-type	epithelium”.
Patients	 with	 atherosclerosis	 and	 hypertension	 had	
changes	 in	 the	 epithelium	 of	 toothless	 jaw	 area	
compared	 with	 the	 control	 group.	 Outgrowths	 in	
lamina	 propria	 were	 significant	 in	 the	 basal	 layer	
(Figure 10-ІІ).	 Stratification	 of	 epithelium	 had	 no	
changes.	The	 surface	 of	 epithelial	 had	 the	 signs	 of	
desquamation.
The	 patients’	 osteocytes	 from	 control	 group	 had	 a	
strong	 and	 high	 expression	 of	 osteopontin	 (Figure 
11-A).	Osteopontin	had	an	ability	to	bind	quite	firmly	
to	hydroxyapatite,	and	connect	with	mineralized	bone	
tissue. Bone tissue of toothless alveolar bone had a 
significant	decrease	in	the	expression	of	osteopontin	
of	the	patients	with	arteriosclerosis.	We	observed	the	
absent	of	osteopontin	expression	in	osteocytes	on	the	
surface of trabeculae (Figure 11-В), but in the middle 
of	trabecular	the	weak	expression	of	osteopontin	was	
preserved	(Figure 11-С).
In	 our	 studies	 we	 have	 analyzed	 a	 number	 of	
morphological	parameters	in	study	groups:
•	 the	thickness	of	the	cortical	bone;
•	 number of cortical bone osteocytes and 
osteoclasts;	
•	 the	thickness	of	the	trabecular	toothless	area	
of	alveolar	bone	and	periapical	third	part	of	
the	tooth;
•	 number of osteoclasts and osteocytes in 
trabecular	 periapical	 third	 part	 of	 the	 tooth	
and toothless alveolar bone.
	 We	 have	 also	 statistically	 processed	 a	 degree	 of	
bone	 fluorescencetion	 and	 volume	 of	 osteopontin	
expression.
In	 our	 studies	 we	 have	 used	 xi-squared	 test,	
implemented	 in	ХІ2ТЕСТ	function	 in	Excel	 to	 test	
the	normality.	The	arguments	were	the	range	of	the	
control	 group	 and	 the	 range	 of	 the	 experimental	
group	for	the	appropriate	intervals.
ХІ2ТЕСТ	 function	 in	 Excel	 calculates	 the	
probability	 of	 the	 observed	 convergence	 of	 control	
and	experimental	values.	If	the	calculated	probability	
was	lower	than	the	significance	level	(0.05),	the	null	
hypothesis	would	be	rejected	and	confirmed	that	the	
observed values did not meet the normal distribution. 
If	the	calculated	probability	was	close	to	1,	then	a	high	
degree	of	compliance	of	experimental	data	to	normal	
distribution	would	be	confirmed.	The	obtained	data	
are	presented	in	Table 1.
Analysis	of	the	data	presented	in	Table	1	shows	that	
five	 out	 of	 twelve	 indicators	 correspond	 to	 normal	
distribution, and the rest of them do not meet the 
normal	distribution.	On	 the	basis	of	used	xi-square	
test	we	can	test	the	hypothesis	of	equality	of	samples	
Ansari-Bradley	 criterion.	 The	 results	 of	 samples	
analysis are given in Table 2.
Based	 on	 the	 statistical	 analysis	 we	 can	 see	 a	
downward	 trend	 in	 the	 number	 of	 osteocytes	 in	
trabeculae	 of	 the	 periapical	 third	 part	 of	 the	 tooth	
at	 atherosclerosis	 P=0.05.	 We	 can	 also	 see	 the	
dependence	of	trabecular	thinning	of	toothless	area	of	
the	alveolar	bone	P=0.02	from	losing	of	teeth	against	
the	background	of	atherosclerosis	with	hypertension.	
The	 osteopontin	 expression	 and	 fluorescencetion	
of toothless bone area also tend to decrease in 
atherosclerosis	and	hypertension	P=0.48	and	P=0.49.
In	 order	 to	 clarify	 the	 pathogenic	 links	 between	
statistically	significant	indicators	(fluorescencetion	of	the	
toothless	bone	area	of	the	alveolar	process,	%;	expression	
of	osteopontin,	%;	the	thickness	of	the	trabecular	toothless	
area	of	the	alveolar	bone,	microns;	number	of	osteocytes	
in	 the	 trabecular	 periapical	 third	part	 of	 the	 tooth	with	
increasing)	we	have	conducted	cluster	analysis	using	the	
method	of	k-means.	Based	on	cluster	analysis	we	have	
created dendrohrama (Figure 12). 
Indicators	of	 the	first	group	have	been	merged	 into	
a	 cluster	 on	 the	 first	 stage	 of	 clustering	 (red line 
Figure 12).	The	first	cluster	describes	the	changes	of	
organic	component	of	the	bone.	It	can	be	argued	with	
certainty	 that	 reducing	 expression	 of	 osteopontin	
causes	 changes	 in	 the	 organic	 part	 of	 the	 bone	 in	
hypertension	with	arteriosclerosis.
Ateriosclerosis	 in	 combination	 with	 hypertension	
leads to changes of the number of osteocytes in 
trabeculae	 of	 the	 periapical	 third	 part	 of	 the	 tooth,	
which	 causes	 changes	 of	 thickness	 in	 trabeculae	 of	
the	toothless	alveolar	bone.	These	figures	are	included	
into the second cluster (Figure 12 green line) and 
determine	the	progression	of	secondary	osteoporosis.
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Discussion:
Osteoporosis	may	affect	the	jawbones	16. In addition, 
these	 modifications	 might	 potentially	 speed	 up	
the	 periodontal	 tissues	 breakdown	 caused	 by	
periodontitis	17.
The	 second	 disease	 that	 increases	 possibility	 of	
osteoporosis	 is	 pancreatic	 diabetes	 of	 type	 II.	 These	
patients	have	heightened	BMD.	 It	 is	 confirmed	by	 the	
results of meta-analysis 18	but	the	risk	of	osteoporosis	also	
increases. Our studies have demonstrated the existence of 
some	other	potentially	important	periodontal	risk	factors	
of	osteoporosis	in	the	jaw.	Atherosclerosis	and	toothless	
jaw	increase	the	risk	of	the	second	type	of	osteoporosis	
in	the	jaw.	According	to	some	studies,	osteoporosis	may	
be	a	very	important	factor	of	adentia	19-21.
Kribbs et al. 22	Ana	Pejčićet	al.23	compared	patients	
with	osteoporosis	and	without	it	and	found	out	that	
the	 osteoporoticgroup	 comprised	 more	 subjects	
with	no	teeth	or	with	agreater	number	of	lost	teeth.
Our	 studies	 showed	 morphological	 changes	 that	
confirmed	the	clinical	opinions	of	Kribbs	et	al.,	Ana	
Pejčićet	 al.	 Diabetes,	 atherosclerosis	 and	 adentia	
have formatted bone tissue disorders and its strength 
decreases.	It	 is	confirmed	by	the	investigations	that	
point	 out	 at	 decrease	 of	 osteoblasts	 activity	 24 that 
slows	 down	 the	 curation	 process	 after	 fractures25. 
Oxidative	stress	has	played	a	part	in	the	development	
of	 osteoporosis	 26.	 Reactive	 oxygen	 species	 has	
oxygen-containing	 molecules	 that	 are	 produced	
during normal metabolism. 
When	 the	 production	 of	 the	 damaging	 reactive	
oxygen	 species	 exceeds	 the	 capacity	 of	 the	 body’s	
antioxidant defenses to detoxify them, a condition 
known	as	oxidative	stress	occurs	27. Reactive oxygen 
species	 can	 cause	 bone	 tissue	 damage,	 particularly	
in the endothelial tissue 28.	 Lipids	 and	 lipoproteins	
are	 also	 affected	 by	 reactive	 oxygen	 species.	 The	
oxidative	 modification	 hypothesis	 suggests	 that	
lipids	and	proteins	oxidation	in	the	vascular	wall	may	
cause atherosclerosis.
Our	studies	have	showed	that	the	fluorescence	decrease	
of	 bone	 toothless	 alveolar	 process	 in	 patients	 with	
hypertension	 and	 atherosclerosis	 is	 lower	 	 compared	
with	 the	 patients	 of	 the	 test	 group.	 Hydroxyproline	
and	 pyridine	 promote	 bone	 strength	 by	 the	 covalent	
bonds	 between	 amino	 acids	 comprising	 the	 collagen	
polypeptide	 chains.	 Reduced	 hydroxyproline	 and	
pyridine	 lead	 to	 the	decrease	of	fluorescence	and	 to	a	
consequent	decrease	of	 the	number	of	bonds	between	
molecules	 of	 collagen	 within	 the	 bone.	We	 observed	
osteopontin	 reduction	 in	 patients	 with	 atherosclerosis	
and	hypertension.	We	believe	that	reducing	the	synthetic	
activity	of	cells	associated	with	cells	hypoxia	is	caused	
by	arteriosclerosis	and	reactive	oxygen	species.	Hypoxia	
promotes	osteolysis	with	the	acid	metabolic	products	in	
osteocytes. Metabolic acidosis forms a large amount of 
heavy	acids	as	pyruvates	and	lactates.
The	results	of	our	studies	have	shown	the	association	
of	osteopontin	expression	and	the	level	of	the	bone	
fluorescence	in	the	cluster	analysis,	that	decrease	the	
expression	 of	 osteopontin	 which	 leads	 to	 acidosis	
due	to	decrease	in	production	of	the	bone	matrix	and	
consequently	 reducing	 the	 thickness	 of	 trabeculae.	
Оsteolysis	 by	 osteocytes	 causes	 the	 expansion	 of	
bone	 tubules.	Compact	 layer	and	spongy	substance	
of the toothless alveolar bone in the control 
and	 experimental	 group	 are	 associated	 with	 the	
synthesis	 and	 secretion	of	proteolytic	 enzymes	 and	
acid	 metabolic	 products	 in	 osteocytes	 under	 the	
influence	of	 chewing	pressure.	Under	 the	 influence	
of	arteriosclerosis	this	process	is	more	intense.	These	
causes decreased the number of osteocytes around 
tooth	root,	as	a	result	of	 the	bone	thinness.	Spongy	
bone regeneration is an area of the alveolar ridge. It 
is	possible	to	assume	that	changes	in	bone	resorptive	
in	the	adjacent	area	of	the	defect	of	teeth	contribute	
to	 the	development	of	 secondary	osteoporosis.	The	
number	 of	 osteocytes	 and	 trabecular	 thickness	 of	
toothless	 alveolar	 process	 indicate	 in	 favor	 of	 this.	
Оsteocytes	 and	 trabecular	 thickness	 have	 merged	
into one cluster in the statistical analysis.
Conclusion
The	 cause	 of	 tooth	 loss	 is	 difficult	 to	 determine,	
since	it	is	not	clear	whether	it	is	due	to	osteoporosis	
or	some	forms	of	periodontitis	in	patients.	The	bone	
resorption	 has	 actived	 by	 reactive	 oxygen	 species	
both	 during	 atherosclerosis.	 Through	 our	 research	
found out that in order to reduce changes in the 
toothless	 bone	 we	 should	 reduce	 the	 pressure	 on	
chewing	toothless	alveolar	sprout	by	dental	implants.
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Table 2: Investigated indicators of patients groups and Ansari-Bradley’s criteria values
Sample name m±SDat n=7, Group 1
m±SDat n=7, 
Group 2
P value of 
Ansari-Bradley 
criterion
Fluorescencetion of toothless bone area of 
alveolar	process,	% 76.15±25.21		 42.81±16.24		 0.049*
Fluorescencetion	of	bone	of	periapical	third	
part,	% 61.84±12.58		 52.32±17.79		 0.58
Expressio	of	osteopontin,	% 76.14±16.29		 42.81±16.24		 0.048*
The	thickness	of	the	cortical	bone,	microns 4230±622.76		 2357.71±554.32		 1
Number of cortical bone osteocytes, increased 
×	150	 36.42±4.75		 28.71±4.57		 0.43
Number of cortical bone osteoclasts, increased 
×	150 2±1.15 3±0.81		 1
The	thickness	of	the	trabecular	periapical	third	
part	of	the	tooth,	microns 254.28±52.27		 201.85±37.42		 0.68
The	thickness	of	the	trabecular	toothless	area	of	
alveolar bone, microns 376.28±204.38		 226.57±70.53		 0.02*
Number	of	osteoclasts	in	trabecular	periapical	
third	prt	of	the	tooth,	increased	×	150 2.28±0.75		 3.14±0.69		 0.9
Number	of	osteocytes	in	trabecular	periapical	
third	prt	of	the	tooth,	increased	×	150 27±3.69		 26.85±7.44		 0.05*
Number of osteoclasts in trabecular toothless 
alveolar	bone,	increased	×	150 2.57±0.53		 3.14±0.69		 0.7
Number of osteocytes in trabecular toothless 
alveolar	bone,	increased	×	150 27.57±4.89		 26.57±4.07		 0.69
P	=	0.05	-	a	trend	at	f	=	n-1
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